}?>
By Joining you agree to MachPrinciple's Terms and Conditions and Privacy Policy
Click to Login
Please check your email. A registration confirmation link will be sent to your mailbox..
A registration confirmation link has been sent to your email. Please check your email and finish the registration process.
Search a Conference through our dedicated search page
Mutations in Leucine Rich Repeat Kinase 2 are the most common genetic cause of Parkinsona€™s disease, making this multidomain enzyme one of the most promising drug targets for Parkinsona€™s. Following ten years of cellular research into LRRK2, this meeting will take stock of the current state of our understanding of the genetics, cellular function and pharmacology of LRRK2, and look to the future of drug development targeting this complex protein.
It's free and it will always be
© machprinciple.com